Eliot Mark Slovin

Title: Eliot Mark Slovin: Innovator in Biodegradable Pharmaceutical Formulations

Introduction

Eliot Mark Slovin is a notable inventor based in Arlington, TX (US), recognized for his contributions to the field of pharmaceutical formulations. With a total of 4 patents, his work focuses on innovative solutions that enhance drug delivery systems.

Latest Patents

One of Slovin's latest patents is titled "Biodegradable microparticle pharmaceutical formulations exhibiting improved release rates." This invention is directed to an apparatus and method for producing microparticles that comprise pharmacologically active agents and biodegradable polymers. The apparatus features a spinning disk with a central reservoir and a flat inclined surface, which may include serrations or a flat surface beneath the disk's periphery. Additionally, the invention outlines a method for producing microparticles using this spinning disk apparatus, including formulations containing ophthalmically active agents and those exhibiting zero-order release rates.

Another significant patent involves the "Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen." This invention addresses disorders related to the accumulation of drusen, such as dry age-related macular degeneration and geographic atrophy, through the administration of therapeutically effective amounts of at least one monomeric or polymeric cyclodextrin.

Career Highlights

Throughout his career, Slovin has worked with prominent organizations, including the Southwest Research Institute and Novartis AG. His experience in these institutions has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Eliot Mark Slovin has collaborated with notable colleagues, including Joseph T. Persyn and Joseph A. McDonough, further enhancing the impact of his inventions in the pharmaceutical field.

Conclusion

Eliot Mark Slovin's innovative work in biodegradable pharmaceutical formulations and his collaborations with esteemed colleagues highlight his significant contributions to the field. His patents reflect a commitment to advancing drug delivery systems and improving treatment options for various medical conditions.